1Horl WH, Vanrenterghem Y, Canand B, et al. Optimal treatmem of re- nal anaemia (OPTA) : improving the effleacy and effleieney of renal a- naemia therapy in haemodialysis patients receiving intravenous epoetin [ J ]. Nephrol Dial Transplant, 2005,20 ( Suppl 3 ) :iii25 - iii32. 被引量：1
2LocateUi F, Aljama P, Barany P, et al. Revised European bestpractice guidelines for the management of anaemia in patients with chronic renal failure [ J ]. Nephrol Dial Transplant, 2004,19 ( Suppl 2 ) :iil - ii41. 被引量：1
3NKF - K/DOQI clinical practice guidelines for anemia of chronic kidney disease[ M]. New York: National Kidney Foundation,2001:35 -49. 被引量：1
4Cavill I. Intravenous iron as an adjuvant therapy: a twoedged sword [ J ] .9 Nephrol Dial Transplant, 2003,18 ( Suppl ) : viii.24 - viii28. 被引量：1
5Rozen - Zvi B, Gafter - Gvili A, Paul M, et al. Intravenous versus oraliron supplementation for the treatment of anemia in CKD : systematic re- view and meta-analysis[J]. Am J Kidney Dis, 2008,52(5) :897 - 906. 被引量：1
6Glickman JD. Morbidity of anemia in patients with chronic kidney dis- ease[ M]. {kNNA CE Satellite Symposium, 2004, (accessed April 7, 2007 ). 被引量：1
7Van Wyck DB, Roppolo M, Martinez CO, et al. A randomized, con- trolled trial comparing IV iron guerose to oral iron in anemic patients with nondialysis - dependent CKD [ J ]. Kidney Int, 2005,68 ( 6 ) : 2846 - 2856. 被引量：1
8Li H, Wang SX. Intravenous iron sucrose in Chinese hemodialysis pa- tients with renal anemia[ J]. Blood Purif, 2008,26(2 ) :151 -156. 被引量：1
9Sehwenk MH. Femmoxylol: a new intravenous iron preparation for the treatment of iron deficiency anemia in patients with chronic kidney dis- easeF J1. Pharmacothempv. 2010 ~30( 1 ) :70 -79. 被引量：1
10H? fl WH. Clinical aspects of iron use in the anemia of kidney disease IJ]. J Am Soc Nephrol, 2007,18(2) :382 -393. 被引量：1
5Portoles J, Lopez-Gomez JM, Aljama P. Anemia management and treatment response in patients on hemodialysis: the MAR study [J]. J Nephrol, 2006, 19: 352-360. 被引量：1
6Malindrctos P, Sarafldis PA, RudenoI, ct al. Slow intravenous iron ad- ministration does not aggravate oxidative stress and inflammatory biomarkcrs during hemodialysis: a comparative study between iron sucrose and iron dcxtran [J]. Am J Ncphrol, 2007, 27(6): 572-579. 被引量：1
7Anraku M, Kitamura K, Shintomo R, ct al. Effect of intravenous iron administration fi'cqucncy on AOPP and inflammatory biomark- crs in chronic hcmodialysis patients: a pilot study [J]. Clin Bio- chcm, 2008, 41(14-15): I168-I174. 被引量：1
